Skip to main content

UBS Group AG

Position in GDTC — CytoMed Therapeutics Ltd

CIK 1610520 ZURICH, V8

Position in GDTC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,975
-$1,207 QoQ
Shares Held
4,831
-21.9% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 3 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GDTC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. GDTC ranks #473 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GDTC

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,975 4,831
2026-03-31 $6,182 6,182
2025-12-31 $1,421 1,065
2025-09-30 $26,444 13,289
2025-06-30 $39,556 17,581
2025-03-31 $31,493 14,447
2024-12-31 $34,333 10,098
2024-09-30 $95 61
2023-12-31 $17,150 3,500
2023-09-30 $1,669 477
2023-06-30 $164 54